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Relative contribution of intrinsic lung dysfunction and hypoventilation
to hypoxemia during hemodialysis. Two mechanisms have been pro-
posed to explain hemodialysis (HD)-induced hypoxemia: reversible
lung damage due to intrapulmonary leukostasis as a consequence of the
contact of blood with the dialyzer membrane, or alveolar hypoven-
tilation due to the loss of carbon dioxide through the dialyzer. To assess
the role of these factors, seven chronically uremic patients were studied
before and during 4-hr HD sessions using a cuprophane membrane and
either acetate (AHD) or bicarbonate (BHD) dialysate. In AHD only we
observed, by comparison with predialysis values, a significant hy-
poxemia, and a decrease of alveolar ventilation (VA), lung carbon
dioxide output, and respiratory exchange ratio. In both the AHD
hypoxemic group and BHD nonhypoxemic group, there was a similar
decrease in lung carbon dioxide diffusing capacity (DLCO) and of white
blood cells (WBC), and a positive correlation between arterial oxygen
pressure and VA without modification of alveolo arterial P02 differ-
ence, an argument against the existence of ventilation-perfusion or
ventilation-diffusion mismatching. We conclude that, although WBC
sequestration induced a lung damage evidenced by DLCO impairment,
the key factor of hypoxemia observed in AHD was the hypoventilation.
Contributions respectives des lesions pulmonaires intrinseques et de
l'hypoventilation a l'hypoxémie au cours de l'hémodialyse. Deux
mdcanismes ont été proposes pour expliquer l'hypoxemie induite par
l'hemodialyse (HD): lesions pulmonaires réversibles dues a la
leucostase intrapulmonaire, consequence du contact du sang avec la
membrane du dialyseur, ou hypoventilation alvéolaire provoquée par Ia
perte de dioxyde de carbone dans le dialyseur. Pour évaluer le role de
ces facteurs, sept malades atteints d'urémie chronique ont dté étudiés
avant et pendant des hemodialyses réalisées avec une membrane de
cuprophane et soit avec un bain d'acetate (AHD) soit avec un bain de
bicarbonate (BHD). Par comparaison avec les valeurs obtenues avant la
dialyse ii a été observe seulement dans AHD une hypoxémie avec
diminution de Ia ventilation alvéolaire (VA), de l'excrétion pulmonaire
de dioxyde de carbone et du quotient respiratoire. A la fois dans Ic
groupe hypoxemique AHD et dans Ic groupe non hypoxémique BHD, il
a été observe une diminution comparable de Ia capacité de diffusion
pulmonaire pour le dioxyde de carbone (DLCO) et du nombre des
leucocytes circulants (WBC), ainsi qu'une correlation positive entre la
pression partielle d'oxygène dans le sang artériel et la ventilation
alvéolaire sans modification de Ia difference alvéolo artérielle
d'oxygene, ce qui est un argument contre l'existence d'une modification
de l'heterogeneité de distribution des rapports ventilation-perfusion ou
ventilation-diffusion. En conclusion, bien que Ia sequestration
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pulmonaire des leucocytes provoque des lesions pulmonaires traduites
par la diminution de DLCO, l'hypoventilation est le facteur principal de
l'hypoxemie observée au cours de AHD.
Two main mechanisms have been proposed as possible
causes of the transient hypoxemia occurring during
hemodialysis (HD) sessions in patients with chronic renal
failure: reversible lung damage on the one hand [1—3] and
hypoventilation on the other hand [4—9]. Two sequences have
been proposed to account for these mechanisms: (1) blood-
membrane interaction followed by complement activation [2,
10] and leukocyte aggregation in the pulmonary capillary bed
[2], ventilation perfusion mismatching and/or pulmonary inter-
stitial edema [1]; (2) loss of carbon dioxide (C02) through the
dialyzer [11] and decrease of venous blood partial pressure of
C02, decrease of alveolar ventilation [6, 11]. Each sequence is
related to one aspect of the dialysis procedure: Complement
activation and leucocyte aggregation depend on the
physicochemical nature of the dialysis membrane [12—16] and
are especially important with cuprophan membranes [12]; CO2
loss is related to the chemical composition of the dialysate [6,
11], an important loss being observed with low (Pco2) dialysates
(for example, acetate dialysate). The first mechanism can be
assessed by the decrease of blood leukocytes, the decrease of
lung CO2 diffusing capacity and the increase in the alveolo-
arterial P02 difference; the second mechanism can be assessed
by the decrease of lung CO2 output, respiratory quotient, and
alveolar ventilation.
The contribution of those two mechanisms to hypoxemia
remains a matter of controversy as stated by Novello and
Kjellstrand [17]. While the exclusive effect of CO2 loss and
hypoventilation has been advocated by several investigators
[4—91, others still recently reported that hypoxemia could occur
in the absence of any change of alveolar ventilation [3, 12].
Moreover, according to De Backer et al [13] the two mecha-
nisms might combine to induce hypoxemia. Our work was
designed to further investigate the pathophysiology of HD-
induced hypoxemia in seven chronically uremic patients who
were studied firstly during an HD session with an acetate
dialysate (AHD) and secondly during an HD session with a
bicarbonate dialysate (BHD); the same type of cuprophan
membrane was used in either kind of dialysis.
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Such a protocol allowed the analysis of the consequences or
Pa02 of lung damage without hypoventilation during BHD, or
of lung damage with hypoventilation during AHD.
Methods
Two women and five men, ranging in age from 25 to 68 years
(mean, 42 years; SD = 16.8), were studied. They had been on
maintenance HD for 3 to 59 months (mean, 15.4), and under-
went three 4-hr dialysis sessions per week. They were free from
cardiovascular or pulmonary disease. The causes of renal
insufficiency were chronic pyelonephritis (two patients), poly-
cystic kidney disease (two patients), focal glomerular sclerosis
(one patient), or nephropathy of unknown origin (two patients).
Informed consent was obtained from each patient.
Dialysis sessions were performed with a parallel flow dialyzer
(Gambro GLP, Lund, Sweden) and 1 m2 cuprophane mem-
brane. A single pass system was used. The composition of the
dialysate was, in mmoles/liter: sodium, 147; potassium, 2;
magnesium 0.75; calcium, 1.75; and either acetate, 38, or
bicarbonate, 31.5. The Pco2 value (mean SD) in the dialysate
input was 0.67 0.133 kPa (5 1 mm Hg) in AHD procedure
and 12.9 0.67 kPa (97 5 mm Hg) in BHD procedure.
Access to circulation was provided by an internal arteriovenous
fistula. Blood flow ranged from 280 to 320 mI/mm and dialysate
flow from 500 to 800 mI/mm. Patients were in a semirecumbent
position during the entire dialysis session.
The patients were acquainted with the breathing experiments
before starting dialysis. Five samples for ventilatory parameters
and blood determinations were obtained before (t0) and at
selected intervals after the beginning of HD: at 45, 90, 180 and
240 mm (t1 to t4, respectively). The expired gas was collected
via a mouth-piece into a 50-liter bag during 5 mm; fractional
concentrations (FE) of 02 and CO2 and total expired volume
were determined. The ventilation was expressed in BTPS
conditions, the 02 uptake (V02) and the CO2 output (VCO2) in
STPD. The respiratory exchange ratio R (VCO2/V02), the
alveolar ventilation (VA), and the inspired ventilation (VI) were
calculated [according to the equations: VA = VCO2/kPaCO2,
VI = VE x (1 — FEN2)/FIN2]. The physiological dead space,
(VI-VA)/respiratory frequency ratio, was expressed as 100
times physiological dead space/tidal volume. The mean alveolar
02 pressure (AO2) was estimated from the alveolar gas equa-
tion, assuming the mean alveolar CO2 pressure to be equal to
the measured PaCO2: A02 = F102 x (PB — 47 mm Hg) —
PaCO2 x (R — (1 — F102)/R) where PB is atmospheric
pressure.
The alveolar-arterial P02 difference (AaDO2) was obtained by
subtracting the measured Pa02 from the calculated PAO2. The
lung CO2 diffusing capacity (DLCO) was measured in duplicate
before each gas collection with the single breath monoxide test,
according to a previously published protocol [181. Arterial
blood was obtained at the middle point of gas collection:
Determinations included Pa02, PaCO2 and pH (Radiometer
ABL2 Analyser, Copenhagen, Denmark). Bicarbonate
(HCO3—) concentration was calculated from Henderson-
Hasselbalch's equation. Cell counts (red blood cells, platelets,
total and differential leukocytes) and hemoglobin concentration
were obtained with an automatic device (Coulter-Counter,
model S., Coultronics, Miami, Florida). Further information
about the time course of leukocyte count modifications were
Table 1. Predialysis values of respiratory parametersa
AHD BHD
Pa02, kPa 12.9 0.37 12.8 0.50
mm Hg 96.7 2.80 95.9 3.75
PaCO2, kPa 5.2 0.16 4.9 0.23
mm Hg 39.0 1.2 37.0 1.7
pH 7.37; 7.36—7.39 7.35; 7.32—7.37
HC03, mmoles (dm3i' 22.3 1.11 19.9 1.69
DLCO, mmoles min kPa' 4.99 0.509 4.82 0.375
ml min' mm Hg' 14.9 1.52 14.4 1.12
VA, dm3 4.56 0.415 4.55 0.453
'A, dm3 min'/m2 3.4 0.44 3.5 0.21
Phys DS/TV, %
VU2, mmoles mi,r'/m2
25 1.8
5.67 0.388
27 1.7
4.91 0.255
mlmin'/m2 127 8.7 110 5.7
VCO,, mmoles mi,r'1m2 5.18 0.420 4.35 0.201
ml min/m2 116 0.4 97 4.5
R 0.88 0.03 0.87 0.02
AaDO,, kPa 1.3 0.17 1.9 0.19
mm Hg 10.0 1.3 14.0 1.4
Abbreviations: a, arterial blood; DLCO, lung diffusing capacity; TA,
alveolar ventilation; VA, alveolar volume; VU2, lung 02 uptake; VCO2,
lung CO2 output; R, respiratory exchange ratio; AaDO2, alveolar-
arterial P02 difference; Phys DS, physiological dead space; TV, tidal
volume; AHD, acetate hemodialysis; BHD, bicarbonate hemodialysis.
Values are expressed as means SEM. pH values are converted
from mean H ion concentration; mean — 1 SEM and mean + I SEM.
obtained through samples withdrawn 15 mm after the beginning
of AHD or BHD procedure, from six and from four patients,
respectively. A model for gas exchange in the lung [191 was
used to test several mechanisms of hypoxemia.
Individual data were analyzed by analysis of variance, taking
into account two components: between-patients and within-
time variability [20]. All parameters were also expressed as the
percent of the predialysis value to reduce the effect of the
variability between patients. A paired t test was used for the
comparison of the parameters between AHD and BHD proce-
dures. Correlations were performed by searching for a linear
relationship between parameters by the method of least
squares. All data in the text and tables were expressed as mean
SEM.
Results
Pulmonary gas exchange
Table 1 lists the predialysis values of blood gases and
respiratory parameters in AHD and BHD groups. These initial
values did not differ significantly between the two groups.
Figures 1—3 show the evolution, as a function of time, of the
respiratory parameters expressed as a percent of their
predialysis values.
In the AHD group, a significant fall in PaO2 (at 89%, P <
0.001) occurred at t1 and persisted throughout the period of HD,
without significant variation of PaCO2 except at t4 (PaCO2 =
92% of the predialysis value, P < 0:02). The progressive
decrease of VCO2, without alteration of VO2, except for a small
increase at t1 (123% 8.6, P < 0.001), induced a steady
significant decrease of R from t1 to t4 (P < 0.001). There was a
significant decrease of VA from t1 to t4 without significant
change of AaDO2 or physiological dead space.
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Fig. 1. Change in arterial 02 pressure (Pa02) and arterial CO, pressure
(PaC02) during the course of acetate hemodialysis (AHD, •) and
bicarbonate hemodialysis (BHD, 0) in seven patients. Pa02 and PaCO,
are expressed as a percentage of the predialysis value (mean SEM) at
selected intervals after the beginning of dialysis (45, 90, 180, and 240
mm, respectively).
Time, hours
Fig. 3. Change in lung CO2 output (VCO2) and respiratory exchange
ratio (R) during the course of acetate hernodialysis (AHD, •) and
bicarbonate hemodialysis (BHD, 0) in seven patients. VCO2 andR are
expressed as a percentage of predialysis value (mean SEM) at
selected intervals (for explanation of timing, see Fig. I).
o AHD N = 35, r = 0.68, P < 0,001
y 6.5x + 72.3
• BHD N 35, r = 0.52, P< 0.002
y = 5.8x + 75.5
Fig. 2. Change in lung monoxide thifusing capacity (DLCO) and
alveolar ventilation (VA) during the course of acetate hemodialysis
(AHD, •) and bicarbonate hemodialvsis (BHD, 0) in seven patients.
DLCO and VA are expressed as a percentage of predialysis value (mean
sEM) at selected intervals (for explanation of timing, see Fig. I).
DLCO was decreased from t1 to t4. The lowest value was
observed at t3 (79% 2.3, P < 0.001). The value at t4 was
significantly greater than that at t3 (86% 4.2 vs. 79% 2.3,
P < 0.05) but remained below the control value (P < 0.001).
There was no significant variation of alveolar volume measured
during the single breath monoxide test, that is, the DLCO/VA
ratio changed as DLCO. HCO3 concentration was decreased
at t1 (95% 1.1, P < 0.01) but exceeded the predialysis value
at t3 and t4 (respectively, 105% 2, P <0.02; 107% 2.1, P
< 0.001). Hydrogen ion concentration was significantly de-
creased (P < 0.001) at t3 and t4, that is, pH increased from 7.37
at to, to 7.43 at t3 and t4. Thus, throughout the dialysis period,
1 2 3 4 5 6
VA/m2 1dm3)
Fig. 4. Relationship of arterial 02 pressure (Pa02) with alveolar
ventilation (scaled by body surface area, VA/rn2) in the seven patients,
before hemodialvsis and during hemodialysis at four selected intervals
after the beginning of hernodialysis. (For explanation of timing see Fig.
1). Abbreviations: AHD, acetate hemodialysis (N = 35); BHD, bi-
carbonate hemodialysis (N = 35).
Pa02, VA, R, and DLCO were decreased without changes of
AaDO2. It should be noted that Pa02 did not reach its lowest
value at the same time in all patients. The decrease of VA (VA
=
—0.83 liter/mm, P < 0.01), and R (zR =
—0.22, P < 0.001)
were significant at the time of the lowest Pa02 (PaO2 = 12.6
mm Hg, P < 0.00 1). There was a positive correlation of Pa02
with either VA (Fig. 4) and R (r = 0.68, P < 0.001 or r = 0.44,
P < 0.008, respectively) in the 35 determinations obtained from
to to t4 in the seven patients.
In the BHD group no significant variations of Pa02 and
PaCO2 were observed throughout HD. A significant increase in
VCO2 was observed from t1 tot4 (119% 6.4, P <0.01, at t1;
120%
100%
80%
Vco2 R
Pa02 PaCO2
120%
T
100%
80% -
0 2 4 0 2 4
120%
100%
80%
DLCO
120
100
E
0
80
60
0
0 2 4 0 2 4
Time, hours
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AHD BHD
RBC x 10°/i1 3.1 0.21 3 0.17
Hemoglobin, gIdl 8.4 0.61 8 0.50
Mean corpuscular volume, 85.3 2.4 82 2.6
Mean corpuscular Hb concentra-
tion, pg 33.1 0.34 32.8 0.21
Platelets x l0/ii 180.1 17 168.7 21
Leukocytes (total x 10/l) 5.35 0.54 5.29 0.65
Neutrophils x 103/gd 2.94 0.24 3.08 0.35
Lymphocytes x l0/d 1.6 0.34 1.5 0.33
116% 6.4, P < 0.01, at t4) with a small increase in V02 at t1
(120% 3.3, P < 0.01). The variations in VA, physiological
dead space, and R were not significant from t1 to t4. Meanwhile,
the DLCO fell significantly from t1 to t4 (P < 0.001); the lowest
mean values were observed at t2 (77% 3.1, P <0.001). This
was no significant variation of alveolar volume measured during
the single breath monoxide test, that is, the DLCO/VA ratio
changed as DLCO. The HCO concentration increased at and
after t1 (P < 0.001), H concentration decreased at and after t2
(P < 0.001), that is, pH increased from 7.35 (t0) to 7.42 at t4. In
the 35 determinations obtained from to to t4 in the seven
patients, there was a significant positive correlation of Pa02
with VA (Fig. 4) and of VI with VCO2 (r = 0.51, P <0.01 and
r = 0.57, P < 0.001, respectively).
DLCO and acid-base status (HC03 and Htm concentrations
in arterial blood), were not significantly different between AHD
and BHD at t1, t2, t3, and t4.
Blood cell count and hemoglobin concentration
In blood samples from to to t4 the predialysis values (Table 2)
and the timed variations were not significantly different be-
tween AHD and BHD patients. For this reason we pooled the
results. The variations in red blood cell count (RBC), platelets.
and Hb concentration from to to indicated a progressive
hemoconcentration (at the end of HD: RBC = 109% 2.4, P
<0.001; P1 = 115% 7.2, P <0.01; Hb = 110% 2.5, P <
0.001). The mean corpuscular Hb concentration did not vary
significantly. Forty-five minutes after the beginning of HD (t1),
the average leukocyte count decreased to 84% 3.5 of the
predialysis value, P < 0.01 (Table 3). The greatest contributing
cause to this decrease was a drop in the monocyte (52% 5.1,
P < 0.001) and in the lymphocyte counts (71% 4, P < 0.001).
At the end of HD, the lymphocyte count remained diminished
(80% 5.5, P < 0.001), while the monocyte count was no
longer significantly different from the predialysis value (113%
9.4). A rebound in the neutrophil count was observed from t2
(127% 6.9, P < 0.01) until t4 (123% 9.8, P < 0.01).
The complementary study of leukocytes count at t15, in six
patients from the AHD group and four patients from the BHD
group, showed a sharp decrease in neutrophils, as previously
reported [71. Moreover, this decrease also affected the eosin-
ophils and basophils.
Initial value
x l03/d blood
15 mm
% of initial value
Leukocytes 5.14 0.447 25 2.0
(Total) P < 0.001
Neutrophils 2.98 0.259 7.1 2.3
(Total) P < 0.001
Eosinophils 0.22 0.062 25 6.1
(Total) P < 0.001
Basophils 0.07 0.028 43 4.6
(Total) P < 0.001
Monocytes 0.31 0.022 4 1.2
(Total) P < 0.001
Lymphocytes 1.56 0.241 66 4.2
(Total) P < 0.001
aValues are expressed as mean SEM; N = 10 (six patients of the
AHD group and four patients of the BHD group); for details see
Methods. The statistical comparison t15 versus is listed.
Discussion
The decrease of WBC in the present study was similar to that
reported for neutrophils and monocytes [1, 121 and lympho-
cytes [121 by other groups, using chemically similar (that is,
cellulosic, not reused) dialysis membranes. Moreover, a sig-
nificant decrease of eosinophils and basophils was observed.
This decrease is likely to be the consequence of leukocyte
sequestration in the pulmonary capillary bed according to the
following sequence [11: (1) complement activation by the cel-
lophane membrane, as has been demonstrated in animal studies
[2] and confirmed, on the contrary, in a patient with a congenital
C3 deficiency [10]; (2) leukocyte aggregation in the pulmonary
capillary bed [I] inducing ventilation perfusion mismatching
and interstitial pulmonary edema [1, 21.
The decrease of DLCO reported here extends to BHD results
previously obtained during AHD [1, 31. This decrease is related
to alveolar capillary membrane disorder and/or capillary blood
volume decrease because alveolar volume did not change. This
decrease of DLCO probably reflects the pulmonary damage
caused by leukocytes. There are, however, several indications
that the sequence from complement activation to intrinsic lung
dysfunction is not a key factor in the hypoxemia observed
during AHD: (1) the fact that AHD with polyacrylonitril mem-
branes [14, 211 or with reused cuprophane membranes [22] did
produce hypoxemia with only minor leukopenia; (2) the lack of
correlation between the hypoxemia and the degree of
leukopenia or of the C3 activation during AHD [14, 21]; (3) the
absence of increased AaDO2 when actual R is taken into
account [8]: Indeed AaDO2 should increase as a consequence of
increased distribution inhomogeneity of V/ [231 and/or
inhomogeneity of D/Q [19] as shown by the simulation of
pulmonary gas exchange with mathematical models. In the
present study, AaDO2 was in the normal range before dialysis
and did not increase significantly during the period of AHD.
This observation, at variance with a previous report [1], agrees
with the results that take into account the actual R value [8, Ill;
(4) the fact that DLCO was decreased to the same extent in
AHD hypoxemic patients and in BHD nonhypoxemic patients.
In the latter, the lack of significant variation of Pa02, PaCO2,
and AaDO2 confirms that lung damage produced by leukocyte
Table 2. Predialysis values of blood cell count and hemoglobin
concentration"
Table 3. Leukocyte count: initial valuea and values at 15 mm
Abbreviations: RBC, red blood cells; AHD, acetate hemodialysis;
BHD, bicarbonate hemodialysis.
a Values are expressed as mean sEM; N = 7 in AHD and BHD groups.
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sequestration did not induce a significant dysfunction in lung
gas exchange.
The major finding which may account for the hypoxemia is
the hypoventilation, whatever its cause. In the present study,
VA was decreased in the AHD hypoxemic group, and a
significant correlation was obtained between VA and Pa02. The
stability of AaDO2 and of physiological dead space is evidence
against a role of V/Q and/or D/Q mismatching in this hy-
poxemia. This stability of AaDO2 was accounted for by a
decrease of actual R, due mainly to a significant decrease of
VCO2 and a small transient increase in V02 at t1. Similar
variations of V02 and/or VCO2 have already been reported [4,
6, 8, 24—261. The hypoventilation may have been the conse-
quence of: (1) the correction of a predialysis metabolic acidosis
and therefore the decrease of the compensatory hyperventila-
tion [27]; this hypothesis is not valid in the present study since
the variation of acid-base status was similar in BHD
nonhypoxemic and ADH hypoxemic patients; (2) a reflex
response to the loss of CO2 through the dialyzer, a loss which
has been demonstrated with acetate baths [4—8, 281. The bi-
carbonate bath avoided such a loss and thus the hypoventilation
during BHD [7].
In experimental conditions we created, the high level of Pco2
in the bicarbonate dialysate (97 mm Hg, SD = 5) must have
induced a diffusion of CO2 from the bath into the venous blood.
Indeed, we observed a significant increase of VCO2 during
BHD from t1 to t4(Fig. 3). The positive linear correlation
between VCO2 and VI (independent variables) showed that the
increase of VCO2 was obtained through hyperventilation. As in
the AHD group, the determining factor of Pa02 was the
ventilation level, since in BHD there was also a positive linear
correlation between PaO2 and VA (independent variables).
Moreover, the slope and the intercept of this relation are not
statistically different in the BHD and AHD groups (Fig. 4). A
conspicuous effect of intrinsic lung damage on 02 exchange, a
damage evidenced by the DLCO decrease in BHD, was un-
likely because the AaDO2 did not vary significantly all along the
BHD.
These results, in AHD and BHD groups, are therefore
consistent with the following sequence as a cause of the
hypoxemia observed in AHD patients: loss of CO2 through the
dialyzer, hypoventilation with a decrease of lung VCO2 output
to maintain a physiological level of PaCO2; this hypoventilation
induces the decrease of Pa02. The simulation of the lung gas
exchange in AHD, using a model [19], with the mean values of
VA, VO,, VCO2, and DL observed in the present study,
showed that the measured values of Pa02 during AHD are
related to the decrease of VA. This particular kind of
hypoventilation, without a PaCO2 increase, has been demon-
strated in animal studies: Pulmonary ventilation can be de-
pressed by extracorporeal CO2 removal by an extracorporeal
membrane lung [29].
In conclusion, the leukocyte sequestration in the lung, de-
pending on the physico-chemical nature of the dialyzer mem-
brane, induces lung damage as evidenced by a decrease of
DLCO. The hypoxemia, however, is mainly related to hypoven-
tilation, due to the loss of CO2 through the dialyzer. a loss due
to the chemical nature of the dialysate. The clinical implication
of this fact, for example, a more extensive utilization of BHD to
prevent hypoxemia, remains to be established because the
hypoxemia during AHD is usually small and may have no
deleterious effects on dialyzed patients with normal pulmonary
and cardiac function. On the other hand, BHD might be
preferred in chronically uremic patients with permanent hy-
poxemia of respiratory or cardiovascular origin.
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